ET-01 in Subjects With Lateral Canthal Lines, LCL-210
Public ClinicalTrials.gov record NCT04985916. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Trial to Evaluate ET-01 in Subjects With Lateral Canthal Lines
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).
Study identification
- NCT ID
- NCT04985916
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 280 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 25 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 18, 2021
- Primary completion
- Feb 7, 2024
- Completion
- Feb 7, 2024
- Last update posted
- Dec 8, 2024
2021 – 2024
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Eirion Research Site | Scottsdale | Arizona | 85255 | — |
| Eirion Research Site | San Diego | California | 92121 | — |
| Eirion Research Site | Aventura | Florida | 33180 | — |
| Eirion Research Site | Boca Raton | Florida | 33486 | — |
| Eirion Research Site | Miami | Florida | 33137 | — |
| Eirion Research Site | West Palm Beach | Florida | 33401 | — |
| Eirion Research Site | Chicago | Illinois | 60654 | — |
| Eirion Research Site | Louisville | Kentucky | 40241 | — |
| Eirion Research Site | New Orleans | Louisiana | 70124 | — |
| Eirion Research Site | Glenn Dale | Maryland | 20769 | — |
| Eirion Research Site | Clinton Township | Michigan | 48038 | — |
| Eirion Research Site | New Brighton | Minnesota | 55112 | — |
| Eirion Research Site | New York | New York | 10075 | — |
| Eirion Research Site | Exton | Pennsylvania | 19341 | — |
| Eirion Research Site | Newtown Square | Pennsylvania | 19073 | — |
| Eirion Research Site | Greenville | South Carolina | 29615 | — |
| Eirion Research Site | Houston | Texas | 77056 | — |
| Eirion Research Site | Plano | Texas | 75093 | — |
| Eirion Research Site | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04985916, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 8, 2024 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04985916 live on ClinicalTrials.gov.